Alterity Therapeutics Ltd.ASX: ATH

Prana receives approval for open label extension study in AD

· Issued by Alterity Therapeutics Ltd.

Filed with ASX ·

6ix hasn’t read this filing yet.

Alterity Therapeutics Ltd. on 6ix

Later from Alterity Therapeutics

All Alterity Therapeutics news releases